Cigna projects $200 million in savings from earlier AI intervention
Cigna is expanding artificial intelligence tools that identify patients who need help before their conditions worsen, a move the insurer projects will cut medical costs by about $200 million over three years. The expansion, announced July 23, will reach 20% more customers with conditions including cancer, heart disease, kidney disease and high-risk pregnancy.
More than 1,250 Cigna clinicians will use the AI's findings to address health needs sooner. The push comes as hospital care, emergency services and prescription drug costs continue climbing.
"As costs for hospital care, emergency services and prescription drugs continue to rise, we are investing in tools and clinical programs that help customers avoid unnecessary hospitalizations, better manage chronic conditions, and reduce the likelihood of more serious and expensive health events later," Bryan Holgerson, president of Cigna Healthcare U.S., said in the release.
Early results show fewer hospital stays and faster cancer detection
Cigna's existing version of the program already shows measurable outcomes. Patients who engage early have seen a 42% drop in avoidable hospital stays. Cancer screening under the program caught breast, colorectal and lung cancer an average of 55, 46 and 37 days sooner, respectively, than they otherwise would have been found.
Additionally, 72% of customers connected to behavioral health providers saw a "clinically meaningful improvement in depression symptoms." Patients who take part are projected to save about $2,000 a year in medical costs, the basis for Cigna's $200 million estimate.
For professionals working in AI for Healthcare, Cigna's approach offers a case study in measuring AI by patient outcomes and cost shifts rather than task automation alone.
Pharmacy Forward targets faster prescription fulfillment
Cigna's health services division, Evernorth, launched a $100 million AI program called Pharmacy Forward for its specialty pharmacy business, Accredo, according to a July 1 press release. The program aims to cut the time from prescription to medication in half, reduce clinician paperwork time by up to half, and get 90% of patients within a same-day or one-day shipping radius.
The program is expected to generate roughly $400 million in value by 2028. Meanwhile, Cigna's AI-powered summarization tool has cut note-taking time by up to 90% for clinicians working within the company's MDLIVE telehealth service, according to a Fortune report.
AI steers patients toward cheaper drug alternatives
Cigna has used AI to study past customer conversations about expensive biologic drugs and their cheaper biosimilar alternatives, then rewrote its outreach based on what worked. More than 80% of targeted customers switched. Humira, one of the biologics Cigna targeted, can cost roughly $7,000 a month.
"That led to a lot more margin," Katya Andresen, chief data, digital and AI officer at Cigna, told Fortune. "But more importantly, it created a couple hundred million dollars of savings for patients."
Across all efforts, Cigna is measuring AI by whether it changes what care patients get and what it costs, not just by how many tasks it automates. That shift lines up with a broader industry trend. The PYMNTS Intelligence report "Enterprise AI Gains Ground, but Scale Remains Uneven" found in August that 84% of healthcare firms expect to increase their budgets for new forms of AI over the next 12 months, including 16% that expect increases of more than 15%.
The same report found that 84% of healthcare firms already report broad or embedded use of new AI tools in their data and technology processes, trailing financial services at 95% but ahead of media companies at 81%. Healthcare firms were just as confident in the results, as 95% called new AI very or extremely effective in the functions where they use it.
Why this matters for healthcare professionals
Cigna's numbers put dollar figures on what AI adoption means for clinical and administrative roles. A 42% reduction in avoidable hospital stays, cancer detected weeks earlier, and a 90% cut in note-taking time are concrete benchmarks you can use when evaluating AI tools in your own organization. For medical billing and coding staff, the cost-savings projections signal where insurers are investing next - and AI for Medical Billers skills will matter more as these systems expand. The message from Cigna's rollout: AI is moving from pilot projects to production systems with hard ROI targets attached.
Your membership also unlocks:
